Clifford Starke - Dec 15, 2023 Form 4 Insider Report for Flora Growth Corp. (FLGC)

Role: CEO, Director
Signature: /s/ Dany Vaiman as attorney-in-fact for Clifford Starke
Stock symbol: FLGC
Transactions as of: Dec 15, 2023
Transactions value $: $48
Form type: 4
Date filed: 9/6/2024, 05:25 PM
Previous filing: Nov 15, 2023
Next filing: Apr 9, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FLGC	Common Shares	Purchase	$48.50	+51	+0.01%	$0.95	474K	Sep 5, 2024	Direct
holding	FLGC	Common Shares						566K	Dec 15, 2023	See footnote	F1
holding	FLGC	Common Shares						300K	Dec 15, 2023	See footnote	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FLGC	Stock Appreciation Rights ("SARs")	Award	$0	+1.03M		$0.00	1.03M	Dec 15, 2023	Common Shares	1.03M	$1.21	Direct	F3
transaction	FLGC	Stock Appreciation Rights ("SARs")	Award	$0	+575K		$0.00	575K	Aug 14, 2024	Common Shares	575K	$0.92	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Held by YT Research, Inc., a company in which the Reporting Person is the sole director and equity owner. The Reporting Person disclaims beneficial ownership of the securities held by YT Research, Inc. except to the extent of his pecuniary interest therein.
F2	Held by Hampstead Private Capital Limited, a company in which the Reporting Person is the sole director and equity owner. The Reporting Person disclaims beneficial ownership of the securities held by Hampstead Private Capital Limited except to the extent of his pecuniary interest therein.
F3	The SARs vest in 12 equal installments, subject to stock price criteria to be met prior to each tranche vesting. The SARs have a post-termination exercise period of one year.